TFF PHARMACEUTICALS, INC. Total Liabilities and Equity
TFF PHARMACEUTICALS, INC. had Total Liabilities and Equity of $7.08 million as of 2024-09-30, per its 10-Q filed 2024-11-20.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2024-11-20
- 2024-09-30: Liabilities and Equity $7.08M.
- 2024-06-30: Liabilities and Equity $9.50M.
- 2024-03-31: Liabilities and Equity $9.19M.
- 2023-12-31: Liabilities and Equity $12.03M.
| Period end | Liabilities and Equity |
|---|---|
| 2024-09-30 | $7.08M 10-Q · filed 2024-11-20 |
| 2024-06-30 | $9.50M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $9.19M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $12.03M 10-Q · filed 2024-11-20 |
| 2023-09-30 | $14.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $13.57M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $18.21M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $24.12M 10-K · filed 2024-03-28 |
| 2022-09-30 | $20.23M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $27.91M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $33.78M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $40.70M 10-K · filed 2023-03-31 |
| 2021-09-30 | $49.30M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $57.15M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $61.35M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $38.66M 10-K · filed 2022-03-24 |
| 2020-09-30 | $43.16M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $22.53M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $26.59M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $29.19M 10-K · filed 2021-03-10 |
| 2019-09-30 | $11.03M 10-Q · filed 2019-12-09 |
| 2018-12-31 | $10.40M 10-K · filed 2020-03-27 |